Application | Comment | Organism |
---|---|---|
medicine | in patients with early Barrett's adenocarcinoma treated with surgery, 91% of cases with low-grade dysplasia show immunoreactivity for alpha-methylacyl-CoA racemase, and 96% of case with high-grade dysplasia and early Barrett's adenocarcinoma are positive for alpha-methylacyl-CoA racemase | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
patients with early Barrett's adenocarcinoma treated with surgery | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
Barrett's epithelium | epithelium that is negative for dysplasia and columnar epithelial cell changes indefinite for dysplasia does not demonstrate immunoreactivity for alpha-methylacyl-Coa racemase. Barrett's epithelium with columnar epithelial cell changes indefinite for dysplasia demonstrates alpha-methylacyl-Coa racemase immunoreactivity in 30% of cases | Homo sapiens | - |